New lines in therapy of Raynaud’s phenomenon-Reference-Cited by-同舟云学术

New lines in therapy of Raynaud’s phenomenon

Published:2008-11-27 Issue:4 Volume:29 Page:355-363
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Lambova Sevdalina Nikolova,Müller-Ladner Ulf

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-008-0792-4.pdf

Reference81 articles.

1. Herrick AL (2003) Treatment of Raynaud’s phenomenon: new insights and developments. Curr Rheumatol Rep 5:168–174

2. Ho M, Belch JJF (1998) Raynaud’s phenomenon: state of the art 1998. Scand J Rheumatol 27:319–322

3. Ling SM, Wigley FM (1999) Raynaud’s phenomenon in older adults. Diagnostic considerations and management. Drugs Aging 15(3):183–195

4. Herric AL, Cerrinic MM (2001) The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 19:4–8

5. Kahaleh B, Meyer O, Scorza R (2003) Assessment of vascular involvement. Clin Exp Rheumatol 21(S29):S9–S14

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations;European Journal of Dermatology;2018-05

2. The importance of perfusion index monitoring in evaluating the efficacy of stellate ganglion blockage treatment in Raynaud’s disease;Libyan Journal of Medicine;2018-01

3. Síndromes acrales vasculares;EMC - Dermatología;2017-06

4. A randomized, single-blinded cross-over trial of ischemic preconditioning in Raynaud's phenomenon;Journal of Scleroderma and Related Disorders;2017-02-09

5. Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms;Frontiers in Pharmacology;2016-11-16